Arbro Pharmaceuticals launches Vkap-D3 for the treatment of Vitamin- D Deficiency in India
We are elated to announce that on 5th of August 2022, we have successfully launched Vkap-D3, a plant-based capsule at Sarovar Portico, Naraina in New Delhi, India. Vkap-D3 contains Vitamin D3 60,000 IU in a unique liquid-filled hard vegetarian capsule shell – made of HPMC (having plant-based origin) to help treat Vitamin D deficiency. Vkap-D3 is presented in a vegetarian capsules shell which will lead to better acceptance with the large vegetarian population of the country who are averse to consuming gelatin capsules. There are various advantages to using HPMC capsules: it is chemically and thermally more stable compared to soft gelatin, making it more suitable for the harsh and varied temperature conditions during distribution and storage in India. Vkap-D3 is an oral, Vitamin D (60,000 IU weekly) regimen that rapidly normalizes 25 (OH) D levels and ensures better symptomatic relief than a daily dosage of 1000 IU for the same duration.Studies indicate that 76 percent of Indians suffer from Vitamin D deficiency and insufficiency. The sedentary lifestyle, less exposure to sunlight, pollution, lack of proper nutrition and consumption of ultra-processed foods is leading to Vitamin D deficiency. Vkap-D3 will be effective in dealing with Vitamin D deficiency in people. Vitamin D facilitates in maintaining the functions of our body’s nerves and muscles, cardiovascular, respiratory, and immune system and improves the overall quality of life.